I am a
Home I AM A Search Login

Papers of the Week


2020 Apr


J Heart Lung Transplant


39


4S

Recombinant Herpes Zoster Vaccine (RZV) after Heart Transplantation: A Single Center Experience.

Authors

Barghash MH, Taimur S, Rana M, Behar J, Lala A, Mitter SS, Moss N, Pinney SP, Mancini D
J Heart Lung Transplant. 2020 Apr; 39(4S):S204.
PMID: 32465067.

Abstract

Herpes zoster (HZ) results from reactivation of latent varicella zoster virus (VZV) presenting as a dermatomal rash. Diminished cellular immunity to VZV increases HZ risk and incidence in solid organ transplant (SOT) is higher than the general population. Immunogenicity and safety of the inactivated varicella vaccine (RZV, Shingrix) has been demonstrated in renal transplant (KT) but data in heart transplant (HT) are lacking.